P4P Technology has been included in the publication *Czech Strategic Technologies 2026/2027*

P4P Technology has long been committed to the research and development of innovative solutions in the fields of medicine and biotechnology. The company’s key project is Plasma for People, which focuses on the development of a blood plasma substitute based on the plant protein edestin. Thanks to a patented purification process, edestin has the potential to become an alternative to human albumin, with an emphasis on greater safety, ethical acceptability and wider availability.

However, the potential applications of edestin are not limited to medicine. In its soluble form, it is a source of all nine essential amino acids and is also used in nutritional supplements under the brand names Feline a Edestine. There is also potential for future applications in cosmetics and dermatology.

A key partner in the Plasma for People project is the company All for Future (A4F), which connects investors with projects focused on long-term development, innovation and social impact.

Its inclusion in the *Czech Strategic Technologies* publication confirms the project’s significance not only for the Czech technology sector, but also for the future development of healthcare and biotechnology.

You can find more information about the project on the website P4P Technology.